MEDNAX Stock Price and Value Analysis

Should you buy MEDNAX stock? (NYSE:MD). Let's see how it does in our automated value investing analysis system.

  • This company has amazingly consistent growth!
  • This company is not making money.
  • This stock looks overpriced.
  • This company is less known than others.
  • This company pays no dividend.

MD Free Cash Flow Trend

Hmm, we can't give any reliable projection for MEDNAX's growth rate. The company either has too few years of historical data for us to examine, or it's in the habit of losing money.

None of this means it's a bad stock. Maybe it's new and growing quickly, or maybe it's turning things around. We can't say anything sensible about it, so we won't say it's obviously undervalued right now. Proceed at your own risk!

Free Cash Flow trendline for MD
Free Cash Flow trendline for MEDNAX

Inside the MD Numbers

MD Price
(MEDNAX stock price per share)
[?] PE Ratio versus Sector 33% lower than other Healthcare stocks
[?] PE Ratio versus Industry 22% lower than other Medical Care stocks
[?] Free Cash Flow Jitter 7%

Is MEDNAX Stock on Sale?

Based on our analysis, we believe that you should not buy MEDNAX right now. It might be a good stock to own—we just can't prove it with value analysis right now. Proceed with caution.

Should You Buy MD Stock?

Does MEDNAX have a coherent story? Does it have a plan to continue to make money? Is it worth your time? Only you can decide where to go from here. Our investment guide helps you ask the right questions, including how to buy stocks. Use these research links for more information.